Skip to content

Released Jun 1, 2026, after the close

10-K filed Jun 1, 2026, 152 days after period end · 0000868278-26-000005

Q4 2025 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$784.00Kderived−47.5% vs Q4 2024−11.2% vs Q3 2025
Net Income-$7.40MderivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$247,000N/M
Operating Incomederived-$5,726,000N/M
Operating Cash Flowderived-$1,230,000N/M
Free Cash Flowderived-$1,230,000N/M
Margins · derived
Gross margin31.5%+41.5 pt vs Q4 2024
Operating margin-730.4%+426.9 pt vs Q4 2024
Net margin-943.6%+1356.2 pt vs Q4 2024

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2025derived from reported figuresQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figures
Revenue$784.00K$1.49M—$21.82M
Net Income-$7.40M-$34.36M-$8.75M-$2.45M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR